Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.

Researcher Publications

Antonina Mitrofanova, PhD

Selected Publications

  • Panja, S., Hayati, S., Epsi, N.J., Parrott, J.S., and Mitrofanova, A. (2018).
    Integrative (epi) genomic analysis to predict response to androgen-deprivation therapy in prostate cancer.
    EBioMedicine (collaboration between Cell Press and THE LANCET),
    Volume 31, ppi: 110-121. PMID: 29685789, accepted April 5, 2018.
    Senior Corresponding author.
  • Dutta, A., Panja, S., Virk, R.V., Kim, J.Y., Zott, R., Cremers, S., Golombos, D.M., Liu, D., Mosquera, J.M., Mostaghel, E.A., Barbieri, C.E., Mitrofanova, A. , and Abate-Shen, C. (2017).
    Co-clinical analysis of a genetically-engineered mouse model and human prostate cancer reveals significance of NKX3.1 expression for response to 5a-reductase inhibition.
    European Urology, pii: S0302-2838(17)30252-X. PMID: 28385453.
    co-Senior co-Corresponding authors.
  • LeMagnen, C., Virk, R., Dutta, A., Kim, J.Y., Panja, S., Lopez Bujanda, Z.A., Califano, A., Drakes, C., Mitrofanova, A. , Abate-Shen, C. (2018).
    Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation
    Disease Models and Mechanisms (accepted September 7, 2018)
    Senior author.
  • Dillon L.W., Hayati, S., Roloff, G.W., Tunc, I., Pirooznia, M., Mitrofanova, A. , Hourigan C.S. (2018).
    Targeted RNA-Sequencing For The Quantification Of Measurable Residual Disease In Acute Myeloid Leukemia
    Haematologica (accepted August 28, 2018, doi:10.3324/haematol.2018.203133)
    Senior author.
  • Chua, C.W., Epsi, N.J., Lei, M., Li, Bo., Bergren, S.K., Cardiff, R.D., Hibshoosh, H., Mitrofanova, A. , and Shen, M.M. (2018).
    Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation.
    eLIFE, 2018 Jan 15;7. PMID: 29334357.
    Senior author.

Return to member profile